Supplementary Data2 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Protein Kinase Regulation and GTPase Signaling
Cancer Genomics and Diagnostics
Publication details
- Publication date
- 1 April 2026
- Language
- EN